Dr. Miguel Fernández de Sanmamed Gutiérrez is a leading medical oncologist in Spain, affiliated with the prestigious Clínica Universidad de Navarra and the Cima Universidad de Navarra. He currently serves as the Principal Investigator of the Onco-Applied and Translational Immunology Group, as well as Co-Coordinator of the Skin Tumor Area at the University of Navarra Cancer Center. With a strong academic foundation and international exposure, Dr. Sanmamed has trained at renowned institutions including Yale University and Stanford University, enriching his global perspective on cancer research and treatment. Recognized for his excellence, Dr. Sanmamed was named a Highly Cited Researcher in 2023 by Web of Science, highlighting his impact in the oncology field. With over 70 scientific publications and multiple awards from leading cancer research societies such as ESMO and AECC, he stands among the top cancer specialists in Spain. His dedication to cancer research and education is reflected in his active teaching roles at the University of Navarra and Yale School of Medicine. As a famous oncologist in Spain, his work continues to inspire the next generation of cancer researchers and physicians.
Dr. Miguel Fernández de Sanmamed Gutiérrez is a recognized expert in cancer immunotherapy, particularly in skin and lung cancers. His clinical focus includes pioneering therapies like T-cell engagers, bispecific monoclonal antibodies, and targeting interleukin-8 pathways. At the Clínica Universidad de Navarra, he leads advanced research on humanized-PDX models to explore new cancer immunotherapy approaches and resistance mechanisms, especially regarding anti-drug antibodies (ADA) and exosomal biomarkers. As a key figure in the Spanish and European oncology research communities, he has been instrumental in several funded projects by institutions such as Asociación Española contra el Cáncer, the Spanish Ministry of Education, and CRIS Contra el Cáncer. His translational research connects laboratory discoveries with real-world cancer treatments, bridging innovation and patient care. Dr. Sanmamed’s innovative work using non-T-cell inflamed models and tumor exosomes places him among the top immunotherapy researchers in Europe. His mentorship of master's and PhD theses on immunotherapy pathways further underlines his role as both a leading researcher and educator in oncology. Patients seeking advanced immunotherapy in Spain often turn to Dr. Sanmamed for his expertise and groundbreaking methods.
Connect with the world's Best Clinic and doctors at Best Clinic Abroad. Your well-being is our priority, with personalized care every step of the way.
How it works?